Gynae BT 2017

Dose to macroscopic nodal disease

139 patients, all EMBRACE

•

All stages cervix cancer, 84 N1

•

• 209 nodes identified •

D98 mean 62 Gy EQD2 (53 to 69)

Including BT contribution

•

• Excellent control in boosted nodes

No relation initial node volume - dose - failure

• Initial SUVmax higher in nodes that relapsed • More failures when chemo < 5 cycles